### Evidence Statement CG15AdultES187
Also reported in the SIGN guideline 174 is a sub-study analysis of a large RCT demonstrating that addition of clopidogrel to aspirin over 312 months reduces the risk of fatal or non-fatal MI or stroke by 20% in patients with a past history of coronary heart disease presenting with acute coronary syndromes (without electrocardiographic ST elevation). This risk reduction was however associated with an additional risk of bleeding

[@Linden_2011]

---
niceevidencecategory: Ia
...


